|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/428 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 25/00 | (2018.01) |
| (11) | Patento numeris | 3240538 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17712175.3 |
| Europos patento paraiškos padavimo data | 2017-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/057134 |
| Data | 2017-03-24 |
| (87) | Numeris | WO 2017/162884 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 16162490 | 2016-03-25 | EP |
| (72) |
MOUSSY, Alain , FR
KINET, Jean-Pierre , FR
MANSFIELD, Colin , FR
|
| (73) |
AB Science ,
3, avenue George V, 75008 Paris,
FR
|
| (54) | USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION |
| USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION |